LBX Pharmacy Chain Joint Stock (603883.SH) plans to contribute 50 million yuan to participate in the Ningbo Zhixing Yueheng Fund.

LBX Pharmacy Chain Joint Stock (603883.SH) announced that, as one of the limited partners, it plans to contribute 50 million yuan from its own funds to subscribe for a partnership share in Ningbo Zhixing Yueheng Venture Capital Partnership (Limited Partnership) (referred to as "Ningbo Zhixing Yueheng"). The partnership primarily invests, directly or indirectly, in investment targets related to artificial intelligence, hardware manufacturing, and applications in various fields such as biomedicine, technology, and consumer goods through equity and other methods permitted by applicable laws. On the premise of ensuring daily operating capital needs and keeping overall investment risks controllable, the company leverages the project resources and investment capabilities of professional investment institutions to explore strategic emerging industries, which is conducive to deepening the company's AI development strategy, enhancing its development potential, and creating greater value for shareholders.